UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 13, 2023

Accession Number:	0001193125-23-065385
Submission Type:	POS AM
CIK: 0001566373 Company Name: F-star Therapeutics, Inc. File Number: 333-234436